The Vanguard Group 13D and 13G filings for SpringWorks Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-31 09:55 am Purchase |
2024-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX |
The Vanguard Group | 7,158,871 9.620% |
1,122,329 (+18.59%) |
Filing |
| 2024-02-13 5:14 pm Purchase |
2023-12-29 | 13G | SpringWorks Therapeutics, Inc. SWTX |
The Vanguard Group | 6,036,542 8.380% |
1,714,187 (+39.66%) |
Filing |
| 2023-02-09 11:32 am Purchase |
2022-12-30 | 13G | SpringWorks Therapeutics, Inc. SWTX |
The Vanguard Group | 4,322,355 6.930% |
1,460,043 (+51.01%) |
Filing |
| 2022-02-10 08:37 am Purchase |
2021-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX |
The Vanguard Group | 2,862,312 5.810% |
2,862,312 (New Position) |
Filing |